Evaluating Glofitamab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evaluating Glofitamab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evaluating Glofitamab Today - Breaking & Trending Today

Study Examining Glofitamab With GemOX in Patients With R/R DLBCL Meets Primary Endpoint

Published: April 19, 2024

Previously, glofitamab had received an accelerated approval for patients with relapsed or refractory diffuse large B-cell lymphoma who received 2 or more prior lines of systemic therapy.

Source: pharmacytimes.com

Related Topics:

Mabthera RituxinLevi GarrawayKrish PatelLymphoma ProgramSwedish Cancer Institute In SeattleGlobal Product Development At RocheEvaluating GlofitamabCombination With GemcitabineParticipants WithRefractory Diffuse Largeb CellSwedish Cancer InstituteGlobal Product Development